Exchange: NASDAQ·Updated 07:58 PM EST

About BLLN

About

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
713

Frequently Asked Questions

Advertisement|Remove ads.